Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-60529 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- VSTM2L Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant full-length protein
- Description
- Immunogen sequence: QWWYVRSHRD WTDKQAWASN QLKASQQEDA GKEATKISVV KVVGSNISHK LRLSRVKPTD EGTYEC
- Concentration
- 0.05 mg/mL
Submitted references High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling.
Liu H, Zhang Z, Zhen P, Zhou M
Journal of immunology research 2021;2021:6657012
Journal of immunology research 2021;2021:6657012
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of VSTM2L in control (vector only transfected HEK293T lysate) and VSTM2L over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (~3.1 kDa) in mammalian HEK293T cells). Samples were probed using a VSTM2L Polyclonal Antibody (Product # PA5-60529).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent staining of VSTM2L in human cell line U-2 OS shows positivity in nucleus but excluded from the nucleoli. Samples were probed using a VSTM2L Polyclonal Antibody (Product # PA5-60529).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical staining of VSTM2L in human urinary bladder tissue shows moderate cytoplasmic and nuclear positivity in urothelial cells. Samples were probed using a VSTM2L Polyclonal Antibody (Product # PA5-60529).
